Genomatica secures lead investor to bring equity investments to $90m

By Becky Bargh 23-Oct-2018

Lead investors include Casdin Capital, Viking Global Investors and Ginkgo Bioworks

Chemical manufacturing company Genomatica has secured US$90m of equity investments following a drive to increase capital.

Sign up for your free email newsletter

Participants include new lead investor...

This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.
Subscribe now to premium content on Cosmetics Business